Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study.

Saved in:
Bibliographic Details
Title: Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study.
Authors: Minhaj FS; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: rhu5@cdc.gov., Mandra A; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Nguete BU; Kinshasa School of Public Health, Kinshasa, DR Congo., Likafi T; Ministry of Health, Kinshasa, DR Congo., Kokola G; Ministry of Health, Kinshasa, DR Congo., Tran S; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kennedy JL; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Monroe B; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hughes CM; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Joseph T; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Person MK; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Townsend MB; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Satheshkumar PS; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kabamba J; Centers for Disease Control and Prevention, Kinshasa, DR Congo., Reynolds MG; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Rao AK; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kasongo D; Ministry of Health, Kinshasa, DR Congo., Yu PA; Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA., Yu Y; Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA., Shongo Lushima R; Ministry of Health, Kinshasa, DR Congo., Kaba D; Kinshasa School of Public Health, Kinshasa, DR Congo., Petersen B; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., McCollum AM; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2026 Jun; Vol. 26 (6), pp. 561-570. Date of Electronic Publication: 2026 Mar 09.
Publication Type: Clinical Trial, Phase III; Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-4457
DOI:10.1016/S1473-3099(25)00779-0